Doximity Past Earnings Performance
Past criteria checks 5/6
Doximity has been growing earnings at an average annual rate of 35.3%, while the Healthcare Services industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 17.8% per year. Doximity's return on equity is 18.1%, and it has net margins of 33.7%.
Key information
35.3%
Earnings growth rate
23.0%
EPS growth rate
| Healthcare Services Industry Growth | 19.5% |
| Revenue growth rate | 17.8% |
| Return on equity | 18.1% |
| Net Margin | 33.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Doximity makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 517 | 174 | 176 | 86 |
| 30 Jun 24 | 494 | 161 | 171 | 83 |
| 31 Mar 24 | 475 | 148 | 170 | 82 |
| 31 Dec 23 | 468 | 138 | 169 | 83 |
| 30 Sep 23 | 448 | 123 | 167 | 84 |
| 30 Jun 23 | 437 | 119 | 166 | 83 |
| 31 Mar 23 | 419 | 113 | 160 | 80 |
| 31 Dec 22 | 402 | 119 | 153 | 76 |
| 30 Sep 22 | 384 | 141 | 146 | 72 |
| 30 Jun 22 | 362 | 148 | 138 | 68 |
| 31 Mar 22 | 344 | 133 | 128 | 62 |
| 31 Dec 21 | 317 | 107 | 114 | 57 |
| 30 Sep 21 | 277 | 57 | 101 | 53 |
| 30 Jun 21 | 243 | 30 | 88 | 47 |
| 31 Mar 21 | 207 | 22 | 78 | 44 |
| 31 Dec 20 | 177 | 14 | 67 | 40 |
| 31 Mar 20 | 116 | 11 | 46 | 32 |
| 31 Mar 19 | 86 | 1 | 40 | 27 |
Quality Earnings: D2OC34 has high quality earnings.
Growing Profit Margin: D2OC34's current net profit margins (33.7%) are higher than last year (27.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: D2OC34's earnings have grown significantly by 35.3% per year over the past 5 years.
Accelerating Growth: D2OC34's earnings growth over the past year (41.4%) exceeds its 5-year average (35.3% per year).
Earnings vs Industry: D2OC34 earnings growth over the past year (41.4%) exceeded the Healthcare Services industry 21.3%.
Return on Equity
High ROE: D2OC34's Return on Equity (18.1%) is considered low.